Counterfeit products and product piracy are serious issues for the pharmaceutical industry – but recent product marking requirements in developed economies, including the US and …
The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% …
The U.S. Food and Drug Administration today approved a magnetic device system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. The …
The new implantable tool can be sutured onto tissue and is designed to allow localised, refillable and targeted therapy for the heart. An international team …
Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced that the company accomplished a first closing of its Series C funding round. The company …
MedTech data management enabler MEDEI ApS today released an Industry Advisory outlining changes and advice that medical device manufacturers can use to comply with the …
Experts from European Commission set to advise EU regulatory affairs professionals on new regulation The Regulatory Affairs Professionals Society (RAPS) has announced its full line-up …
Dance Biopharm Holdings Inc. (“Dance”), a privately-held biotechnology company focused on the development of Dance 501, a proprietary ‘soft-mist’ inhaled insulin product to treat diabetes, …
Phillips-Medisize, a Molex company, will be exhibiting at K39 in hall 8a during COMPAMED 2017. COMPAMED takes place simultaneously with the Medica exhibition on November …
As a full-service provider, Gerresheimer Medical Systems will be attending the Compamed trade fair in Düsseldorf from November 13 to 16, with an exhibit at …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
